Hiromasa Fujita

Mortality and Morbidity Rates, Postoperative Course, Quality of Life, and Prognosis After Extended Radical Lymphadenectomy for Esophageal Gancer

Hiromasa Fujita, Teruo Kakegawa, Hideaki Yamana et al. · Annals of Surgery · 1995 · 401 citations · Full text

Medicine, Oncology, Surgery +10

Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population

Genta Sawada, Atsushi Niida, Ryutaro Uchi et al. · Gastroenterology · 2016 · 341 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

Tomoya Sudo, T. Utsunomiya, Koshi Mimori et al. · British Journal of Cancer · 2005 · 238 citations · Full text

Medicine, Molecular Biology, Oncology +12

Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7

Norio Komatsu, Masahiro Yamamoto, Hiromasa Fujita et al. · Blood · 1993 · 166 citations · Full text

Life Sciences, Cell Biology, Hematology +4

Optimum Treatment Strategy for Superficial Esophageal Cancer: Endoscopic Mucosal Resection versus Radical Esophagectomy

Hiromasa Fujita, Susumu Sueyoshi, Hideaki Yamana et al. · World Journal of Surgery · 2001 · 160 citations

Medicine, Oncology, Surgery +12